Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blankestijn, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blankestijn, P. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 1975-1978
© 2001 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Treatment and prevention of catheter-related infections in haemodialysis patients

Peter J. Blankestijn

Department of Nephrology, University Medical Center, Utrecht, The Netherlands

Keywords: catheter-related infection; haemodialysis

Introduction

The most important catheter-related complications, which determine method survival, are infection and dysfunction. In particular, infectious episodes are in some studies the leading cause for untimely catheter removal and for catheter-related morbidity but also for morbidity in dialysis patients. For instance, in one study involving 988 dialysis patients it was estimated that the relative risk for bacteraemia was increased more than 7-fold in patients with catheters than in those with AV fistulas [1]. Therefore, identifying appropriate treatment regimens of documented infections, and of measures aimed to prevent infections, is of major clinical relevance.

We have to distinguish between catheters meant for temporary use (i.e. not more than a few weeks) and catheters meant to be in place for months, maybe years.

We will briefly touch first upon temporary catheters and review the updated KDOQI guidelines, which were released in early 2001. Subsequently we will address the issue of . . . [Full Text of this Article]

Pathogenesis

Temporary catheters
Permanent catheters
Prevention

Conclusion

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NDT PlusHome page
S. Eloot, J.-Y. De Vos, and R. Hombrouckx
How much is red blood cell fragmentation increased by the use of closed luer lock access devices on catheter hubs?
NDT Plus, December 1, 2008; 1(6): 409 - 411.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. C. Weijmer, M. A. van den Dorpel, P. J.G. Van de Ven, P. M. ter Wee, J. A.C.A. van Geelen, J. O. Groeneveld, B. C. van Jaarsveld, M. G. Koopmans, C. Y. le Poole, A. M. Schrander-Van der Meer, et al.
Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2769 - 2777.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. C. Weijmer, Y. J. Debets-Ossenkopp, F. J. van de Vondervoort, and P. M. ter Wee
Superior antimicrobial activity of trisodium citrate over heparin for catheter locking
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2189 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
V. Mickley
Central venous catheters: many questions, few answers
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1368 - 1373.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Vardhan, J. Davies, I. Daryanani, A. Crowe, and P. McClelland
Treatment of haemodialysis catheter-related infections
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1149 - 1150.
[Full Text] [PDF]